Neuropathology Core
Neuropathology Core
批准号:
10409745
负责人:
Thomas J Montine
金额:
$36.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-01 至 2025-03-31
关键词:
Alzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAutopsyAwardBiological AssayBiological MarkersBrainBrain regionClinical DataCognitiveConsensusCountryDataDementiaDevelopmentDiagnosticDisciplineDiseaseEnvironmentEvaluationFacultyFormalinFosteringFreezingFutureGuidelinesImageImpaired cognitionIndividualInterdisciplinary StudyInternationalLeadershipMedical StudentsMethodsMissionMolecularNerve DegenerationNeurodegenerative DisordersOutreach ResearchParaffin EmbeddingPathologicPathologic ProcessesPatientsPhysiciansPositioning AttributeProcessReportingResearchResearch PersonnelResource SharingScientistSpecimenStructureTechniquesTechnologyTimeTissue EmbeddingTissuesTrainingTranslational ResearchVisionaging brainbiobankbrain researchbrain tissuedata managementdata qualitydiagnostic criteriaeducation researchgraduate studentimaging approachinnovationinnovative technologiesinsightmolecular pathologyneuropathologyrepositoryresearch studystatistics
中文摘要
1.总结(神经病理学核心)
神经病理学核心支持斯坦福大学阿尔茨海默病中心(ADRC)的愿景,
一个共享的资源,以促进和加强多学科和跨学科的研究阿尔茨海默氏症
疾病(AD)和相关病症。核心的结构是为了继续其促进和应用
创新的尖端技术,重点是大脑老化和病理过程的多样性
这是由AD和相关疾病引起的认知障碍和痴呆的基础。关键职能
神经病理学核心包括诊断专业知识,作为生物储存库,促进创新,
训练在过去的五年里,神经病理学核心已经完成了50多个研究性的大脑解剖,
并在制定和评估国家神经病理学研究指南方面担任领导职务。
AD的评价。我们已经储存了800多个组织标本,为当地提供了数据和生物标本,
区域,国家和国际研究和财团,并促进发展,
在转化研究中实施创新技术。通过核心,我们培训临床医生
以及来自不同学科的神经病理学和痴呆相关的分子病理学的科学家,
神经退行性疾病神经病理学核心将通过四个具体目标来实现其使命。的
核心将为医生和研究人员提供全面的神经病理学评估,
描述AD和相关疾病神经病理学特征的全面尸检报告
根据最新指南和共识诊断标准。它将保持并继续
将其高度可及但受到适当保护的脑组织和生物标本储存库从
仔细和纵向特征的认知障碍或痴呆患者,以及认知
正常个体,使用增加和最大化组织和数据质量的方法。在这样做时,核心
将为福尔马林固定、石蜡包埋的组织提供创新的高内涵成像方法,
以及冷冻大脑区域,以最大限度地发挥斯坦福大学ADRC储存库和其他大脑的研究价值。
全国各地的银行。最后,我们将为医学和研究生提供丰富的培训环境,
学生,居民,研究员,和跨部门的初级教师教的概念和国家的最先进的
技术,推进当前的跨学科研究,促进未来的进步和见解,在大脑
老化和神经退化。核心的组织是为了最大限度地与所有其他核心的集成,
斯坦福大学ADRC。它还将继续作为附属的发展成果中心和独立的
通过诊断实践、分子分析和组织共享来获得研究奖励。在这样做时,核心和
中心将继续在全国范围内做出贡献,以促进我们对病理特征的理解,
脑老化的病理生理过程、AD的所有阶段和相关痴呆。
英文摘要
1. SUMMARY (Neuropathology Core)
The Neuropathology Core supports the vision of the Stanford Alzheimer’s Disease Center (ADRC) to serve as
a shared resource to facilitate and enhance multidisciplinary and interdisciplinary research in Alzheimer’s
disease (AD) and related disorders. The Core is structured to continue its track record of enabling and applying
innovative cutting-edge technologies with emphasis on brain aging and the diversity of pathologic processes
that underlie cognitive impairment and dementia caused by AD and related diseases. The critical functions of
the Neuropathology Core include diagnostic expertise, serving as a biorepository, facilitating innovation, and
training. Over the past five years, the Neuropathology Core has completed over 50 research brain autopsies
and held a leadership position in setting and evaluating national research guidelines for neuropathologic
evaluation of AD. We have banked over 800 tissue specimens, contributed data and biospecimens to local,
regional, national, and international research studies and consortia, and fostered development and
implementation of innovative technologies in translational research. Through the Core, we trained clinicians
and scientists from different disciplines in neuropathology and the molecular pathology of dementia-related
neurodegenerative diseases. The Neuropathology Core will pursue its mission through four Specific Aims. The
Core will provide comprehensive neuropathologic evaluations for physicians and researchers with timely and
comprehensive autopsy reports that describe the neuropathologic features of AD and related diseases
according to the most current guidelines and consensus diagnostic criteria. It will maintain and continue to
grow its highly accessible, but appropriately safeguarded, repository of brain tissue and biospecimens from
carefully and longitudinally characterized patients with cognitive impairment or dementia, as well as cognitively
normal individuals, using methods that increase and maximize tissue and data quality. In doing so, the Core
will empower innovative high-content imaging approaches for both formalin-fixed, paraffin-embedded tissue
and for frozen brain regions to maximize the research value of the Stanford ADRC repository and other brain
banks around the country. Finally, we will maintain a rich training environment for medical and graduate
students, residents, fellows, and junior faculty across departments to teach concepts and state-of-the-art
techniques that advance current interdisciplinary research and foster future advances and insights in brain
aging and neurodegeneration. The Core is organized to maximize integration with all other Cores in the
Stanford ADRC. It also will continue to serve as a hub of support for affiliated ADRCs and independent
research awards through diagnostic practices, molecular assays, and tissue sharing. In doing so, the Core and
Center will continue to contribute nationally to advance our understanding of the pathologic features and
pathophysiologic processes of brain aging, all stages of AD, and related dementias.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neuropath Core
-
批准号:10262851
-
项目类别:
-
资助金额:$37.48万
-
财政年份:2021
-
负责人:Thomas J Montine
-
依托单位:
Neuropath Core
-
批准号:10663237
-
项目类别:
-
资助金额:$37.97万
-
财政年份:2021
-
负责人:Thomas J Montine
-
依托单位:
Neuropath Core
-
批准号:10461184
-
项目类别:
-
资助金额:$38.19万
-
财政年份:2021
-
负责人:Thomas J Montine
-
依托单位:
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry
-
批准号:10359193
-
项目类别:
-
资助金额:$46.18万
-
财政年份:2020
-
负责人:Thomas J Montine
-
依托单位:
Neuropathology Core
-
批准号:10176345
-
项目类别:
-
资助金额:$40.89万
-
财政年份:2020
-
负责人:Thomas J Montine
-
依托单位:
Project 2: Particle and brain mapping of CSF proteins using elemental reporters with mass spectrometry
-
批准号:10573262
-
项目类别:
-
资助金额:$48.89万
-
财政年份:2020
-
负责人:Thomas J Montine
-
依托单位:
Neuropathology Core
-
批准号:10385833
-
项目类别:
-
资助金额:$28.75万
-
财政年份:2019
-
负责人:Thomas J Montine
-
依托单位:
Neuropathology Core
-
批准号:10601059
-
项目类别:
-
资助金额:$27.05万
-
财政年份:2019
-
负责人:Thomas J Montine
-
依托单位:
Clinical Genome Resource (ClinGen)
-
批准号:9769097
-
项目类别:
-
资助金额:$299.07万
-
财政年份:2017
-
负责人:Thomas J Montine
-
依托单位:
Clinical Genome Resource (ClinGen)
-
批准号:9930778
-
项目类别:
-
资助金额:$68.17万
-
财政年份:2017
-
负责人:Thomas J Montine
-
依托单位:
Neuropathologic substrates for motor and cognitive impairment in three existing cohort studies of Alzheimer's disease and related dementias
-
批准号:9425480
-
项目类别:
-
资助金额:$388.02万
-
财政年份:2017
-
负责人:Thomas J Montine
-
依托单位:
Core D: Neuropathology Core
-
批准号:9095181
-
项目类别:
-
资助金额:$16.48万
-
财政年份:2016
-
负责人:Thomas J Montine
-
依托单位:
Neuropathologic research on dementia using Nun Study and HAAS data
-
批准号:8526141
-
项目类别:
-
资助金额:$62.77万
-
财政年份:2013
-
负责人:Thomas J Montine
-
依托单位:
Neuropathologic research on dementia using Nun Study and HAAS data
-
批准号:8900504
-
项目类别:
-
资助金额:$7.98万
-
财政年份:2013
-
负责人:Thomas J Montine
-
依托单位:
Udall Center Director's meeting poster award
-
批准号:8768746
-
项目类别:
-
资助金额:$0.25万
-
财政年份:2013
-
负责人:Thomas J Montine
-
依托单位:
Pacific Northwest Udall Center
-
批准号:7897675
-
项目类别:
-
资助金额:$165.63万
-
财政年份:2009
-
负责人:Thomas J Montine
-
依托单位:
White matter damage in age-related cognitive decline
-
批准号:8919486
-
项目类别:
-
资助金额:$4.98万
-
财政年份:2009
-
负责人:Thomas J Montine
-
依托单位:
Administrative Core
-
批准号:9015039
-
项目类别:
-
资助金额:$15.31万
-
财政年份:2009
-
负责人:Thomas J Montine
-
依托单位:
White matter damage in age-related cognitive decline
-
批准号:8457826
-
项目类别:
-
资助金额:$70.15万
-
财政年份:2009
-
负责人:Thomas J Montine
-
依托单位:
White matter damage in age-related cognitive decline
-
批准号:7578785
-
项目类别:
-
资助金额:$127.77万
-
财政年份:2009
-
负责人:Thomas J Montine
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: